Is tapering medications like lamotrigine, quetiapine, and citalopram over 1 month sufficient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Psychiatric Medications: One Month is Generally Sufficient

A one-month tapering period is generally sufficient for medications like lamotrigine, quetiapine, and citalopram, though individual factors may necessitate adjustments to this timeline. 1, 2

General Tapering Principles

  • Gradual tapering is necessary for most psychiatric medications to minimize withdrawal symptoms, with a typical period of 2-4 weeks being appropriate for most patients 1
  • For medications that have been used for only a few months at standard doses, a one-month taper is usually adequate to prevent significant withdrawal symptoms 1, 2
  • Tapering schedules should follow a hyperbolic pattern (smaller reductions as the dose gets lower) rather than linear reductions to maintain consistent receptor occupancy changes 3, 4

Medication-Specific Considerations

Lamotrigine

  • For lamotrigine at moderate doses, a 2-4 week taper is recommended, beginning by reducing to half the dose for 1-2 weeks, then to 25mg every other day for 1-2 weeks before discontinuing 1
  • Even at relatively low doses, gradual tapering helps minimize withdrawal risks and potential adverse effects 1

Antipsychotics (Quetiapine)

  • Quetiapine can be tapered over a 4-week period by reducing the dose by approximately 25% every week 4, 5
  • More gradual tapering may be necessary for patients who have been on higher doses or for longer periods (years rather than months) 5

SSRIs/Antidepressants (Citalopram)

  • Citalopram should be tapered gradually over 2-4 weeks to minimize discontinuation symptoms 2, 3
  • Common SSRI discontinuation symptoms include dizziness, nausea, fatigue, sensory disturbances, anxiety, and irritability 2
  • Unlike fluoxetine (which has a very long half-life), citalopram requires a more structured taper due to its shorter half-life 2

Monitoring During Tapering

  • Follow up with patients at least once during the tapering period to assess for withdrawal symptoms 1
  • Monitor for potential withdrawal symptoms which may include anxiety, insomnia, irritability, and worsening of the original condition 1, 2
  • If withdrawal symptoms emerge, consider slowing the taper rate 1

Special Considerations

  • For patients with a history of seizures, more cautious tapering of lamotrigine is required as abrupt discontinuation could potentially trigger seizures 1
  • If withdrawal symptoms become significant, the taper can be slowed by using smaller decrements 1, 3
  • Withdrawal symptoms are often mistaken for relapse of the underlying condition, which may lead to unnecessary long-term medication use 2, 3

Practical Tapering Schedule

  • Week 1: Reduce each medication by 25% of the original dose 1, 4
  • Week 2: Reduce to 50% of the original dose 1
  • Week 3: Reduce to 25% of the original dose 1, 3
  • Week 4: Further reduce dose (to approximately 12.5% if possible) or take every other day before discontinuing 1, 3

Common Pitfalls to Avoid

  • Tapering too quickly, which can lead to withdrawal symptoms that mimic relapse 2, 3
  • Failing to distinguish between withdrawal symptoms and true relapse of the underlying condition 2
  • Not providing adequate patient education about potential withdrawal symptoms to expect during the tapering process 1
  • Using linear dose reductions rather than hyperbolic reductions (making smaller reductions as the dose gets lower) 3, 4

References

Guideline

Tapering Lamotrigine 50mg After Two Months of Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.